Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: News

Heart patient goes home hours after live-streamed valve replacement

Heart patient goes home hours after live-streamed valve replacement
p p Read More

Sheffield cardiologists demonstrate cutting-edge TAVI procedure

October 10, 2024 News

Johnson & Johnson myeloma drug recommended for NHS use

Johnson & Johnson myeloma drug recommended for NHS use
p p Read More

Teclistamab offers hope for patients exhausting treatment options

October 10, 2024 News

Purespring Therapeutics secures £80 million in Series B funding

Purespring Therapeutics secures £80 million in Series B funding
p p Read More

New investment to advance gene therapies for kidney diseases

October 9, 2024 News

Sanofi launches high-dose flu vaccine in the UK

Sanofi launches high-dose flu vaccine in the UK
p p Read More

New vaccine aims to protect older adults from severe flu complications

October 9, 2024 News

Kyowa Kirin announces positive interim data for lymphoma treatment

Kyowa Kirin announces positive interim data for lymphoma treatment
p p Read More

Real-world studies show effectiveness of mogamulizumab in routine practice

October 8, 2024 News

Astellas and AviadoBio announce exclusive gene therapy deal

Astellas and AviadoBio announce exclusive gene therapy deal
p p Read More

AviadoBio to receive up to £1.8 billion in potential payments

October 8, 2024 News

FluoGuide submits clinical trial application for head and neck cancer treatment

FluoGuide submits clinical trial application for head and neck cancer treatment
p p Read More

Biotech company moves forward with phase 2 trial for precision cancer surgery

October 7, 2024 News

Scottish patients first in UK to access new lung cancer treatment

Scottish patients first in UK to access new lung cancer treatment
p p Read More

Scottish Medicines Consortium recommends pembrolizumab

October 7, 2024 News

IRLAB’s new drug shows promise in treating apathy in Parkinson’s patients

IRLAB’s new drug shows promise in treating apathy in Parkinson’s patients
p p Read More

Phase 1 trial of IRL757 demonstrates good absorption and safety profile

October 3, 2024 News, Uncategorized

ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study

ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study
p p Read More

Largest real-world study demonstrates significant survival advantage

October 3, 2024 News

Posts navigation

Posts pagination

« Previous 1 … 21 22 23 … 59 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy